Knowledge-Based Identification of the ERK2/STAT3 Signal Pathway as a Therapeutic Target for Type 2 Diabetes and Drug Discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Knowledge-Based Identification of the ERK2/STAT3 Signal Pathway as a Therapeutic Target for Type 2 Diabetes and Drug Discovery

Published:2011-07-08 Issue:3 Volume:78 Page:471-476
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:

Author:

Kinoshita Takayoshi,Doi Kentaro,Sugiyama Hajime,Kinoshita Shuhei,Wada Mutsuyo,Naruto Shuji,Tomonaga Atsushi

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Reference40 articles.

1. Diabetes: magnitude and mechanisms;Michael;Clin Diabetes,2010

2. Diagnosis and classification of diabetes mellitus [position statement];American Diabetes Association;Diabetes Care,2006

3. Challenge and approaches to managing type 2 diabetes mellitus;Horton;Curr Diab Rep,2010

4. New therapies for diabesity;Bailey;Curr Diab Rep,2009

5. PPAR agonists: multimodal drugs for the treatment of type 2 diabetes;Gross;Best Pract Res Clin Endocrinol Metab,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct binding modes of a benzothiazole derivative confer structural bases for increasing ERK2 or p38α MAPK selectivity;Biochemical and Biophysical Research Communications;2024-04

2. Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor;Bioorganic & Medicinal Chemistry Letters;2023-09

3. Low Entropic Cost of Binding Confers High Selectivity on an Allosteric ERK2 Inhibitor;2023

4. The Molecular Mechanisms of Panax ginseng in Treating Type 2 Diabetes Mellitus: Network Pharmacology Analysis and Molecular Docking Validation;Evidence-Based Complementary and Alternative Medicine;2022-09-16

5. Identification of a novel target site for ATP-independent ERK2 inhibitors;Biochemical and Biophysical Research Communications;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3